Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 2
2003 4
2004 7
2005 3
2006 5
2007 7
2008 5
2009 7
2010 12
2011 9
2012 6
2013 1
2014 1
2015 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

64 results
Results by year
Filters applied: . Clear all
Page 1
Epidemiological profile of meningococcal disease in the United States.
Harrison LH. Clin Infect Dis 2010 - Review. PMID 20144015 Free PMC article.
Two tetravalent (A/C/Y/W-135) meningococcal vaccines are licensed in the United States: a purified polysaccharide product and a polysaccharide-protein conjugate vaccine. ...A comprehensive program to prevent invasive meningococcal disease in the United States will require vaccination of infants; several conjugate vaccines for infants may become available in the near future. ...
Two tetravalent (A/C/Y/W-135) meningococcal vaccines are licensed in the United States: a purified polysaccharide product and …
Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005.
Harrison LH, et al. J Infect Dis 2010. PMID 20199241 Free PMC article.
BACKGROUND: A quadrivalent meningococcal conjugate vaccine (MCV4) was licensed in the United States in 2005; no serogroup B vaccine is available. ...
BACKGROUND: A quadrivalent meningococcal conjugate vaccine (MCV4) was licensed in the United States in 2005; no serogroup B va …
Effect of pneumococcal conjugate vaccine on pneumococcal meningitis
Hsu HE, et al. N Engl J Med 2009. PMID 19144940 Free PMC article.
METHODS: We examined trends in pneumococcal meningitis from 1998 through 2005 using active, population-based surveillance data from eight sites in the United States. ...
METHODS: We examined trends in pneumococcal meningitis from 1998 through 2005 using active, population-based surveillance data from eight si …
Antigenic shift and increased incidence of meningococcal disease
Harrison LH, et al. J Infect Dis 2006. PMID 16586364
BACKGROUND: The incidence of serogroup C and Y meningococcal disease increased in the United States during the 1990s. The cyclical nature of endemic meningococcal disease remains unexplained. ...
BACKGROUND: The incidence of serogroup C and Y meningococcal disease increased in the United States during the 1990s. The cycl …
Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccine.
Beernink PT, et al. J Infect Dis 2007 - Clinical Trial. PMID 17436227 Free PMC article.
There are limited data on the prevalence of strains expressing different fHBP variants in the United States. METHODS: A total of 143 group B isolates from patients hospitalized in the United States were tested for fHBP variant by quantitative polymerase chain reaction, for reactivity with 6 anti-fHBP monoclonal antibodies (MAb) by dot immunoblotting, and for susceptibility to bactericidal activity of mouse antisera. ...Both vaccines have the potential to prevent most group B disease in the United States....
There are limited data on the prevalence of strains expressing different fHBP variants in the United States. METHODS: A total …
Multilocus variable-number tandem repeat analysis distinguishes outbreak and sporadic Escherichia coli O157:H7 isolates
Noller AC, et al. J Clin Microbiol 2003. PMID 14662916 Free PMC article.
Escherichia coli O157:H7 is a major cause of food-borne illness in the United States. Outbreak detection involves traditional epidemiological methods and routine molecular subtyping by pulsed-field gel electrophoresis (PFGE). ...
Escherichia coli O157:H7 is a major cause of food-borne illness in the United States. Outbreak detection involves traditional …
64 results
Jump to page
Feedback